Literature DB >> 8030228

Defective measles virus in human subacute sclerosing panencephalitis brain.

M S Sidhu1, J Crowley, A Lowenthal, D Karcher, J Menonna, S Cook, S Udem, P Dowling.   

Abstract

Evidence is presented showing that the brain cells of patients with subacute sclerosing panencephalitis (SSPE) contain mutant measles (MV) genomes having the characteristics of 5' copy-back defective interfering (DI) RNAs. Using a polymerase chain reaction-based amplification specific for copy-back DIs, abundant, discrete cDNAs representing different-sized MV defective RNA species were generated from each SSPE brain. The defective genomes were cloned in two portions. The most common of these defective species were sequenced, confirming their MV genome origin and 5' copy-back nature. We deduced that the minimum DI stem length of these species was 95 nucleotides, further delimiting the prerequisite 5' regulatory region sequences specifying MV genomic replication/encapsidation functions. This calculation assumes a precise copy-back mechanism and complete complementarity of the panhandle structure. Since the SSPE-derived viral genome encodes dysfunctional viral envelope proteins, we hypothesize that SSPE brains may lack the high degree of selective pressure encountered in tissue culture MV infections. This allows for the coexistence of numerous replication-competent defective particles in each SSPE brain. A role for viral defective particles as modulators of this persistent measles virus infection of humans is proposed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8030228     DOI: 10.1006/viro.1994.1384

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 2.  MMR vaccination and autism : what is the evidence for a causal association?

Authors:  Kreesten M Madsen; Mogens Vestergaard
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 3.  Subacute sclerosing panencephalitis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2002-02       Impact factor: 2.401

4.  The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif (GNNNNN)3 is essential for replication.

Authors:  C Tapparel; D Maurice; L Roux
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

Review 5.  Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited.

Authors:  D Kolakofsky; T Pelet; D Garcin; S Hausmann; J Curran; L Roux
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Case of the month.

Authors:  P Wingenfeld; B Schmidt; U Querfeld; D Michalk
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

Review 7.  Within host RNA virus persistence: mechanisms and consequences.

Authors:  Richard E Randall; Diane E Griffin
Journal:  Curr Opin Virol       Date:  2017-03-17       Impact factor: 7.090

8.  Characterization of measles virus strains causing SSPE: a study of 11 cases.

Authors:  L Jin; S Beard; R Hunjan; D W G Brown; E Miller
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

9.  Immune response-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and central nervous system disease.

Authors:  D M Lawrence; M M Vaughn; A R Belman; J S Cole; G F Rall
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  RNA replication for the paramyxovirus simian virus 5 requires an internal repeated (CGNNNN) sequence motif.

Authors:  S K Murphy; G D Parks
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.